908 Devices Inc. (MASS)
NASDAQ:MASS
Want to see MASS full AI Analyst Report?
MASS Stock Chart & Stats
$6.20
-$0.07(-3.29%)
At close: 4:00 PM EST
$6.20
-$0.07(-3.29%)
Day’s Range― - ―
52-Week Range$4.21 - $9.34
Previous CloseN/A
Volume74.64K
Average Volume (3M)251.41K
Market Cap
$260.91M
Enterprise Value$197.82M
Total Cash (Recent Filing)$111.74M
Total Debt (Recent Filing)$4.47M
Price to Earnings (P/E)―
Beta1.06
Next Earnings
Aug 11, 2026EPS Estimate
-0.15Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.98
Shares Outstanding37,813,620
10 Day Avg. Volume264,155
30 Day Avg. Volume251,408
Financial Highlights & Ratios
PEG Ratio0.04
Price to Book (P/B)1.32
Price to Sales (P/S)3.38
P/FCF Ratio-7.72
Enterprise Value/Market Cap0.76
Enterprise Value/Revenue3.42
Enterprise Value/Gross Profit6.98
Enterprise Value/Ebitda-10.28
Forecast
1Y Price Target
$10.00Price Target Upside61.29% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering3
EPS Forecast (FY)-0.41
Revenue Forecast (FY)$65.94M
Bulls Say, Bears Say
Bulls Say
Profitability TrajectoryCompany delivered positive adjusted EBITDA alongside improving gross margins and narrowing operating losses, indicating meaningful progress toward sustainable profitability and positive free cash flow.
Revenue And Product RampAnalyst notes revenue beat driven by strong sales to state and local customers, accelerating international demand for VipIR units, and steady federal and defense orders, supporting future top-line momentum.
Strategic Partnership ProductionAVCAD partnership with Smiths Detection entering initial production is expected to contribute incremental revenue and support scaling of higher-margin product sales.
Bears Say
Customer Demand TrendsAnalyst highlights limited clarity on demand trends across state, federal, and international channels, which raises questions about the sustainability of recent order momentum.
Guidance AssumptionsAnalyst seeks clearer disclosure of the assumptions behind revenue and margin guidance, creating uncertainty about the credibility of the company outlook.
New Product AdoptionAnalyst requests more detail on adoption rates for new offerings like VipIR and AVCAD integrations, leaving uncertainty about how quickly these products will translate into steady revenue growth.
908 Devices News
MASS FAQ
What was 908 Devices Inc.’s price range in the past 12 months?
908 Devices Inc. lowest stock price was $4.21 and its highest was $9.34 in the past 12 months.
What is 908 Devices Inc.’s market cap?
908 Devices Inc.’s market cap is $260.91M.
When is 908 Devices Inc.’s upcoming earnings report date?
908 Devices Inc.’s upcoming earnings report date is Aug 11, 2026 which is in 87 days.
How were 908 Devices Inc.’s earnings last quarter?
908 Devices Inc. released its earnings results on May 06, 2026. The company reported -$0.082 earnings per share for the quarter, beating the consensus estimate of -$0.14 by $0.058.
Is 908 Devices Inc. overvalued?
According to Wall Street analysts 908 Devices Inc.’s price is currently Undervalued.
Does 908 Devices Inc. pay dividends?
908 Devices Inc. does not currently pay dividends.
What is 908 Devices Inc.’s EPS estimate?
908 Devices Inc.’s EPS estimate is -0.15.
How many shares outstanding does 908 Devices Inc. have?
908 Devices Inc. has 37,813,620 shares outstanding.
What happened to 908 Devices Inc.’s price movement after its last earnings report?
908 Devices Inc. reported an EPS of -$0.082 in its last earnings report, beating expectations of -$0.14. Following the earnings report the stock price went up 13.681%.
Which hedge fund is a major shareholder of 908 Devices Inc.?
Currently, no hedge funds are holding shares in MASS
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
908 Devices Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$10.00 (61.29% Upside)
$10.00 (61.29% Upside)
Blogger Sentiment
Bullish
MASS Sentiment 100%
Sector Average 72%
Sector Average 72%
Hedge Fund Trend
Increased
By 54.4K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $821.0K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.3%
Last 30 Days ▼ 5.6%
Last 30 Days ▼ 5.6%
Technicals
SMA
Positive
20 days / 200 days
Momentum
50.57%
12-Months-Change
Fundamentals
Return on Equity
-25.62%
Trailing 12-Months
Asset Growth
-4.76%
Trailing 12-Months
Company Description
908 Devices Inc.
908 Devices Inc., a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry (Mass Spec) devices to interrogate unknown and invisible materials in life sciences research, bioprocessing, industrial biotech, forensics, and adjacent markets. The company's products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of gas, liquid, and solid materials of unknown identity; Rebel, a small desktop analyzer that provides real-time information on the extracellular environment in bioprocesses; and ZipChip solution, a plug-and-play, high-resolution separation platform that optimizes Mass Spec sample analysis. It operates in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company was incorporated in 2012 and is headquartered in Boston, Massachusetts.
MASS Company Deck
MASS Earnings Call
Q1 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call conveys a predominantly positive operational and strategic trajectory: revenue and handheld product growth, improved margins, reduced adjusted EBITDA loss, strong cash position, and the strategic acquisition of NIRLAB that accelerates recurring revenue and expands addressable markets. Key near-term negatives include a wider GAAP net loss driven by a noncash contingent consideration revaluation, a decline in recurring revenue this quarter driven by service reductions, and a modest near-term EBITDA drag from NIRLAB as it is integrated and scaled in the U.S. On balance, the highlights (revenue growth, margin expansion, device momentum, strengthened guidance, cash balance, and accretive M&A strategy) significantly outweigh the lowlights, which are largely one-time accounting charges or manageable integration risks.View all MASS earnings summariesMASS Stock 12 Month Forecast
Average Price Target
$10.00
▲(61.29% Upside)
Technical Analysis
Senseonics Holdings
―
Quanterix
―
Nano-X Imaging
―
TriSalus Life Sciences
―
Cytek Biosciences
―
Ownership Overview
37.15% Insiders
10.61% Mutual Funds
16.10% Other Institutional Investors
23.88% Public Companies and
Individual Investors